Proof of Concept in a Case Study of Glioblastoma Multiforme Successfully Treated with IV Quercetin in Combination with Leading Edge Gamma Knife and Standard Treatments — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Proof of Concept in a Case Study of Glioblastoma Multiforme Successfully Treated with IV Quercetin in Combination with Leading Edge Gamma Knife and Standard Treatments
Pacific Medical Center of Hope, Fresno, USA
,
Brain Tumor Program at Hoag Hospital, Newport Beach, USA
1 Pacific Medical Center of Hope, Fresno, USA
2 Brain Tumor Program at Hoag Hospital, Newport Beach, USA
The Stupp protocol has become standard of care for the treatment of glioblastoma (GBM) (since its publication in 2005) and has led to some limited survival improvements. This protocol, consists of radiotherapy and concomitant chemotherapy with temozolomide, an alkylating agent. Temozolomide + radiation, compared to radiation alone had added in average 3 months additional life span, 16 percent improved survival at 2 years. That said since 2005, the standard of care has not changed in regards to the treatment of early diagnosed aggressive or multifocal GBM, and unfortunately the expected survival is still poor with 75 percent of patients dying in less than 2 years and average survival of 15 months. In patients with multifocal tumors (such as the case below) the average survival is even worse with less than 4 months at her age [1]. Here we present a case study of a patient with advanced multifocal, and rapidly progressing Glioblastoma Multiforme treated with STUPP protocol in combination with IV Quercetin. The patient experienced improved quality of life and response, compared to historical data. It is our recommendation to investigate such combinational approach in patients with Glioblastoma, as in our case it proved to be safe and effective with improved quality of life and performance as well as clinical response and survival.
Di Carlo, D.T., Cagnazzo, F., Benedetto, N., Morganti, R. and Perrini, P. (2017) Multiple High-Grade Gliomas: Epidemiology, Management, and Outcome. A Systematic Review and Meta-Analysis. Neurosurgical Review, 2017, No. 14. https://doi.org/10.1007/s10143-017-0928-7
Patil, C.G., Yi, A., Elramsisy, A., Hu, J., Mukherjee, D., Irvin, D.K., Yu, J.S., Bannykh, S.I., Black, K.L. and Nuno, M. (2012) Prognosis of Patients with Multifocal Glioblastoma: A Case-Control Study. Journal of Neurosurgery, 117, 705-711 https://doi.org/10.3171/2012.7.JNS12147
Li, et al. (2016) Quercetin Sensitizes Glioblastoma to t-AUCB by Dual Inhibition of Hsp27 and COX-2 in Vitro and in Vivo. Journal of Experimental & Clinical Cancer Research, 35, 61. https://doi.org/10.1186/s13046-016-0331-1
Markus, D., Siegelin David, E., Antje, R., Abdelhaq, H., Andreas, R. and von Deimling (2009) Quercetin Promotes Degradation of Survivin and Thereby Enhances Death-Receptor-Mediated Apoptosis in Glioma Cells. Neuro-Oncology, 11, 122-131. https://doi.org/10.1215/15228517-2008-085
Pozsgai, E., Bellyei, S., Cseh, A., Boronkai, A., Racz, B., Szabo, A. and Sumegi, B. (2013) Quercetin Increases the Efficacy of Glioblastoma Treatment Compared to Standard Chemoradiotherapy by the Suppression of PI-3-kinase-Akt Pathway. Nutrition and Cancer, 65, 1059-1066. https://doi.org/10.1080/01635581.2013.810291
Liu, Y., Tang, Z.-G., Lin, Y., Qu, X.-G., Lv, W. and Wang, G.-B. (2017) Effects of Quercetin on Proliferation and Migration of Human Glioblastoma U251 Cells. Biomedicine & Pharmacotherapy, 92, 33-38. https://doi.org/10.1016/j.biopha.2017.05.044
Sang, D.-P., Li, R.-J. and Lan, Q. (2014) Quercetin Sensitizes Human Glioblastoma Cells to Temozolomide in Vitro via Inhibition of Hsp27. Acta Pharmacologica Sinica, 35, 832-838. https://doi.org/10.1038/aps.2014.22
Barbarisi, M., Iaffaioli, R.V., Armenia, E., Schiavo, L., De Sena, G., Tafuto, S., Barbarisi, A. and Quagliariello, V. (2017) Novel Nanohydrogel of Hyaluronic Acid Loaded with Quercetin Alone and in Combination with Temozolomide as New Therapeutic Tool, CD44 Targeted Based, of Glioblastoma Multiforme. Journal of Cellular Physiology.
Hu, J., Wang, J.J., Wang, G., Yao, Z.J. and Dang, X.Q. (2016) Pharmacokinetics and Antitumor Efficacy of DSPE-PEG2000 Polymeric Liposomes Loaded with Quercetin and Temozolomide: Analysis of Their Effectiveness in Enhancing the Chemosensitization of Drug-Resistant Glioma Cells. Internationla Journal of Molecular Medicine, 37, 690-702. https://doi.org/10.3892/ijmm.2016.2458
Hu, K.L., Miao, L., Goodwin, T.J., Li, J., Liu, Q. and Huang, L. (2017) Quercetin Remodels the Tumor Microenvironment to Improve the Permeation, Retention, and Antitumor Effects of Nanoparticles. ACS Nano, 11, 4916-4925. https://doi.org/10.1021/acsnano.7b01522
El Amrawy, F., Othman, A.A., Adkin, C., Helmy, A. and Nounou, M.I. (2016) Tailored Nanocarriers and Bioconjugates for Combating Glioblastoma and Other Brain Tumors. Journal of Cancer Metastasis and Treatment, 2, 112-122. https://doi.org/10.20517/2394-4722.2015.78
de Oliveira, M.R., Nabavi, S.M., Braidy, N., Setzerd, W.N., Ahmed, T. and Nabavi, S.F. (2015) Quercetin and the Mitochondria: A Mechanistic View. Biotechnology Advances, 34, 532-549. https://doi.org/10.1016/j.biotechadv.2015.12.014
Vengoji, R., Macha, M.A., Batra, S.K. and Shonka, N.A. (2018) Natural Products: A Hope for Glioblastoma Patients. Oncotarget, 9, 22194-22219. https://doi.org/10.18632/oncotarget.25175
Jakubowicz-Gil, Langer, E., Badziul, D., Wertel, I. and Rzeski, W. (2013) Silencing of Hsp27 and Hsp72 in Glioma Cells as a Tool for Programmed Cell Death Induction upon Temozolomide and Quercetin Treatment. Toxicology and Applied Pharmacology, 273, 580-589. https://doi.org/10.1016/j.taap.2013.10.003
Combs S.E., Schmid, T.E., Vaupel, P. and Multhoff, G. (2016) Stress Response Leading to Resistance in Glioblastoma—The Need for Innovative Radiotherapy (iRT) Concepts. Cancers (Basel), 13, pii: E15. https://doi.org/10.3390/cancers8010015
Savale, S.K. (2017) Formulation and Evaluation of Quercetin Nanoemulsions for Treatment of Brain Tumor via Intranasal Pathway. Asian Journal of Biomaterial Research, 3, 28-32.
Reddy, R., et al. (2016) Natural Flavonoids Silymarin and Quercetin Improve the Brain Distribution of Co-Administered P-gp Substrate Drugs. SpringerPlus, 5, 1618. https://doi.org/10.1186/s40064-016-3267-1
Hu, J., Wang, J., Wang, G., Yao, Z. and Dang, X. (2016) Pharmacokinetics and Antitumor Efficacy of DSPE-PEG2000 Polymeric Liposomes Loaded with Quercetin and Temozolomide: Analysis of Their Effectiveness in Enhancing the Chemosensitization of Drug-Resistant Glioma Cells. Journal of Molecular Medicine, 37, 690-702. https://doi.org/10.3892/ijmm.2016.2458
Duma, C.M., Kim, B.S., Chen, P.V., Plunkett, M.E., Mackintosh, R., Mathews, M.S., Casserly, R.M., Mendez, G.A., Furman, D.J., Smith, G., Oh, N., Caraway, C.A., Sanathara, A.R., Dillman, R.O., Riley, A.S., Weiland, D., Stemler, L., Cannell, R., Abrams, D.A., Smith, A., Owen, C.M., Eisenberg, B. and Brant-Zawadzki, M. (2016) Upfront Boost Gamma Knife “Leading-Edge” Radiosurgery to FLAIR MRI-Defined Tumor Migration Pathways in 174 Patients with Glioblastoma Multiforme: A 15-Year Assessment of a Novel Therapy. Journal of Neurosurgery, 125, 40-49.
Wong, E., Nahar, N., Hau, E., Varikatt, W., Gebski, V., Ng, T., Jayamohan, J. and Sundaresan, P. (2018) Cut-Point for Ki-67 Proliferation Index as a Prognostic Marker for Glioblastoma. Asia-Pacific Journal of Clinical Oncology. https://doi.org/10.1111/ajco.12826
Gao, F., Cui, Y., Jiang, H., Sui, D., Wang, Y., Jiang, Z., Zhao, J. and Lin, S. (2016) Circulating Tumor Cell Is a Common Property of Brain Glioma and Promotes the Monitoring System. Oncotarget, 7, 71330-71340. https://doi.org/10.18632/oncotarget.11114